Racial Disparities in Pneumococcal Vaccination in Managed Care

This study has been completed.
Sponsor:
Collaborator:
Kaiser Permanente
Information provided by:
Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier:
NCT00229762
First received: September 28, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
  Purpose

The goal of the study was to determine effectiveness of a telephone reminder to increase pneumococcal vaccination in a managed care population.


Condition Intervention
Pneumococcal Disease Prevention
Behavioral: phone call from nurses - informational only

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single Blind
Primary Purpose: Educational/Counseling/Training
Official Title: Racial Disparities in Pneumococcal Vaccination in Managed Care: the Effects of Randomized Telephone Outreach

Further study details as provided by Centers for Disease Control and Prevention:

Primary Outcome Measures:
  • pneumococcal vaccination coverage

Estimated Enrollment: 7000
Study Start Date: March 2004
Estimated Study Completion Date: June 2005
Detailed Description:

Patients randomized to the intervention arm received a telephone call from managed care nurses asking about their pneumococcal vaccination status and whether they would like to be vaccinated. We compared six month follow-up of pneumococcal vaccination in electronic medical records for the intervention versus control group. We tested the percent vaccinated in each randomization arm using chi-square tests for proportions.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

- recommended for pneumococcal vaccination according to age or medical comorbidity

Exclusion Criteria:

- already known to have received pneumococcal vaccine

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00229762

Locations
United States, Georgia
Kaiser Permanente
Atlanta, Georgia, United States, 30333
Sponsors and Collaborators
Kaiser Permanente
Investigators
Principal Investigator: Carla A Winston, PhD Centers for Disease Control and Prevention
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00229762     History of Changes
Other Study ID Numbers: CDC-NIP-4252, 000HCJ4-2004-07797
Study First Received: September 28, 2005
Last Updated: September 28, 2005
Health Authority: United States: Federal Government

Keywords provided by Centers for Disease Control and Prevention:
pneumococcal vaccination coverage with no disease or efficacy outcomes recorded

ClinicalTrials.gov processed this record on April 21, 2014